Frédéric André

Frédéric André

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAlexandra Canonici
Alexandra Canonici
EPEmilie Pellegrino
Emilie Pellegrino
CSCarole Siret
Carole Siret
CTChloé Terciolo
Chloé Terciolo
DCDorota Czerucka
Dorota Czerucka
FAFrédéric André
Frédéric André
Intestinal epithelial cell damage is frequently seen in the mucosal lesions of infectious or inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. Complete remission of these diseases requires both the disappearance of inflammation and the repair of damaged epithelium. Saccharomyces boulardii (Sb, Biocodex) is a non-pathogenic yeast widely used as a preventive and therapeutic probiotic for the prevention and treatment of diarrhea and other gastrointestinal disorders. We recently showed that it enhances the repair of intestinal epithelium through activation of α2β1 integrin collagen receptors. In the present study, we demonstrated that α2β1 integrin is not the sole cell-extracellular matrix receptor involved during Sb-mediated intestinal restitution. Indeed, by using cell adhesion assays, we showed that Sb supernatant contains heat sensitive molecule(s), with a molecular weight higher than 9 kDa, which decreased αvβ5 integrin-mediated adhesion to vitronectin by competing with the integrin. Moreover, Sb-mediated changes in cell adhesion to vitronectin resulted in a reduction of the αvβ5signaling pathway. We used a monolayer wounding assay that mimics in vivo cell restitution to demonstrate that down-modulation of the αvβ5 integrin-vitronectin interaction is related to Sb-induced cell migration. We therefore postulated that Sb supernatant contains motogenic factors that enhance cell restitution through multiple pathways, including the dynamic fine regulation of αvβ5 integrin binding activity. This could be of major importance in diseases characterized by severe mucosal injury, such as inflammatory and infectious bowel diseases.

29 October 2015 in British Journal of Cancer
Verified
Journal Article
Open access
CSCarole Siret
Carole Siret
CTChloé Terciolo
Chloé Terciolo
ADAurelie Dobric
Aurelie Dobric
MHMarie-Christine Habib
Marie-Christine Habib
SGSebastien Germain
Sebastien Germain
FAFrédéric André
Frédéric André
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.

21 November 2017 in British Journal of Cancer
Verified
Journal Article
Open access
CSCarole Siret
Carole Siret
ADAurélie Dobric
Aurélie Dobric
AMAnna Martirosyan
Anna Martirosyan
CTChloé Terciolo
Chloé Terciolo
SGSébastien Germain
Sébastien Germain
FAFrédéric André
Frédéric André
Pancreatic ductal adenocarcinoma (PDAC) is characterised by an extensive tissue invasion and an early formation of metastasis. Alterations in the expression of cadherins have been reported in PDAC. Yet, how these changes contribute to tumour progression is poorly understood. Here, we investigated the relationship between cadherins expression and PDAC development. Cadherins expression was assessed by immunostaining in both human and murine tissue specimens. We have generated pancreatic cancer cell lines expressing both cadherin-1 and cadherin-3 or only one of these cadherins. Functional implications of such genetic alterations were analysed both in vitro and in vivo. Cadherin-3 is detected early at the plasma membrane during progression of pancreatic intraepithelial neoplasia 1 (PanIN-1) to PDAC. Despite tumoural cells turn on cadherin-3, a significant amount of cadherin-1 remains expressed at the cell surface during tumourigenesis. We found that cadherin-3 regulates tumour growth, while cadherin-1 drives type I collagen organisation in the tumour. In vitro assays showed that cadherins differentially participate to PDAC aggressiveness. Cadherin-3 regulates cell migration, whereas cadherin-1 takes part in the invadopodia activity. Our results show differential, but complementary, roles for cadherins during PDAC carcinogenesis and illustrate how their expression conditions the PDAC aggressiveness.

Verified
Journal Article
Open access
PDF file
AVAndrea Dalle Vedove
Andrea Dalle Vedove
FFFederico Falchi
Federico Falchi
SDStefano Donini
Stefano Donini
ADAurélie Dobric
Aurélie Dobric
SGSebastien Germain
Sebastien Germain
EPEmilio Parisini
Emilio Parisini
Cadherins are a large family of transmembrane calcium-dependent cell adhesion proteins that orchestrate adherens junction formation and are crucially involved in tissue morphogenesis. Due to their important role in cancer development and metastasis, cadherins can be considered attractive targets for drug discovery. A recent crystal structure of the complex of a cadherin extracellular portion and a small molecule inhibitor allowed the identification of a druggable interface, thus providing a viable strategy for the design of cadherin dimerization modulators. Here, we report on a structure-based virtual screening approach that led to the identification of efficient and selective modulators of E-cadherin-mediated cell–cell adhesion. Of all the putative inhibitors that were identified and experimentally tested by cell adhesion assays using human pancreatic tumor BxPC-3 cells expressing both E-cadherin and P-cadherin, two compounds turned out to be effective in inhibiting stable cell–cell adhesion at micromolar concentrations. Moreover, at the same concentrations, one of them also showed anti-invasive properties in cell invasion assays. These results will allow further development of novel and selective cadherin-mediated cell–cell adhesion modulators for the treatment of a variety of cadherin-expressing solid tumors and for improving the efficiency of drug delivery across biological barriers.

14 May 2025 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
ADAurélie Dobric
Aurélie Dobric
SGSébastien Germain
Sébastien Germain
FSFrançoise Silvy
Françoise Silvy
RBRénaté Bonier
Rénaté Bonier
SAStéphane Audebert
Stéphane Audebert
FAFrédéric André
Frédéric André
The appearance of hybrid epithelial–mesenchymal (E/M) cells expressing E‐cadherin is favourable for the establishment of pro‐invasive function. Although the potential role of E‐cadherin in cancer invasion is now accepted, the molecular mechanisms involved in this process are not completely elucidated. To gain further insight, we focused our analysis on invadopodia formation, an early event in the invasion process. We used models of E/M hybrid cell lines, tissue sections and patient‐derived xenografts from a multi‐centre clinical trial. E‐cadherin involvement in invadopodia formation was assessed using a gelatin‐FITC degradation assay. Mechanistic studies were performed by using proteomic analysis, siRNA strategy and proximity ligation assay. We showed that E‐cadherin is a critical component of invadopodia. This unexpected localization results from a synergistic trafficking of E‐cadherin and MT1‐MMP through a Rab vesicle‐dependent pathway. Modulation of E‐cadherin expression or activation impacted invadopodia formation. Moreover, colocalization of E‐cadherin and Actin in “ring structures” as precursors of invadopodia reveals that E‐cadherin is required for invadopodia structuration. E‐cadherin, initially localised in the adherens junctions, could be recycled to nascent invadopodia where it will interact with several components enriched in invadopodia, such as Arp2/3, Cortactin or MT1‐MMP. The trans‐adhesive properties of E‐cadherin are therefore essential for structuring invadopodia. This new localisation of E‐cadherin and its unexpected role in cell invasion shine a new light on hybrid E/M transition features in tumoral invasion.

9 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAurélie Dobric
Aurélie Dobric
SGSébastien Germain
Sébastien Germain
FSFrançoise Silvy
Françoise Silvy
RBRénaté Bonier
Rénaté Bonier
SAstephane Audebert
stephane Audebert
FAFrédéric André
Frédéric André
Graphical Background: The appearance of hybrid epithelial-mesenchymal (E/M) cells expressing E-cadherin is favourable for the establishment of pro-invasive function. However, the molecular mechanism and potential roles of E-cadherin in cancer cell invasion stay unexplored. Methods: We used models of E/M hybrid cell lines, tissues sections and patient-derived xenografts from a multi-center clinical trial. E-cadherin involvement in invadopodia formation was assessed using a gelatin-FITC degradation assay. Mechanistic studies were performed by using proteomic analysis, siRNA strategy and proximity ligation assay. Results: We showed that E-cadherin is a critical component of invadopodia. This unexpected localization results from a synergistic trafficking of E-cadherin and MT1-MMP through Rab vesicle-dependent pathway. Modulation of E-cadherin expression or activation impacted invadopodia formation. Moreover, colocalization of E-cadherin and Actin in ―ring structures‖ as precursor of invadopodia reveals that E-cadherin is required for invadopodia structuration. Conclusion: E-cadherin, initially localized in the adherens junctions could be recycled to nascent invadopodia where it will interact with several components such as Arp2/3, Cortactin or MT1-MMP. The trans-adhesive properties of E-cadherin are therefore essential for structuring invadopodia .